Kerry A. Wentworth

2012

In 2012, Kerry A. Wentworth earned a total compensation of $824.4K as Vice President, Clinical, Regulatory and Quality at Agenus, a 21% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$40,778
Option Awards$325,691
Salary$260,762
Stock Awards$189,197
Other$7,938
Total$824,366

Wentworth received $325.7K in option awards, accounting for 40% of the total pay in 2012.

Wentworth also received $40.8K in non-equity incentive plan, $260.8K in salary, $189.2K in stock awards and $7.9K in other compensation.

Rankings

In 2012, Kerry A. Wentworth's compensation ranked 6,897th out of 11,487 executives tracked by ExecPay. In other words, Wentworth earned more than 40.0% of executives.

ClassificationRankingPercentile
All
6,897
out of 11,487
40th
Division
Manufacturing
2,474
out of 4,253
42nd
Major group
Chemicals And Allied Products
629
out of 1,203
48th
Industry group
Drugs
431
out of 925
53rd
Industry
Biological Products, Except Diagnostic Substances
72
out of 165
56th
Source: SEC filing on March 10, 2014.

Wentworth's colleagues

We found four more compensation records of executives who worked with Kerry A. Wentworth at Agenus in 2012.

2012

Garo Armen

Agenus

Chief Executive Officer

2012

Karen Valentine

Agenus

General Counsel

2012

Christine Klaskin

Agenus

Vice President, Finance

2012

Shalini Sharp

Agenus

Chief Financial Officer

You may also like